percutaneous ethanol injection

DRUG2 trials

Sponsors

Sohag University, Hospital Israelita Albert Einstein

Conditions

Cost EffectivenessExposure to RadiofrequencyHepatocellular Carcinoma

Unknown Phase

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

CompletedNCT04553458

Sohag UniversityHepatocellular Carcinoma

Start: 2015-06-30End: 2020-06-30Updated: 2020-09-17

Cost-effectiveness of RFA vs. PEI for Early-stage HCC

CompletedNCT06450613

Hospital Israelita Albert EinsteinCost Effectiveness, Exposure to Radiofrequency

Start: 2018-01-01End: 2021-03-31Updated: 2024-06-10

Related Papers

Cost-effectiveness of radiofrequency ablation versus percutaneous ethanol injection for early hepatocellular carcinoma in a resource-poor setting: a randomized trial.

2024-09-301 citations